Healthcare  Name:  Sector:  Chief Executive: Memory Pharmaceuticals Healthcare James Sulat  Summary: Discovers and develops mechanism-based treatments for aging and memory-related disorders.                    Stage of Initial  Investment: Seed/Early  Liquidity: IPO (NASDAQ: MEMY) 100 Philips Parkway Montvale, NJ 07645 Phone: 201.802.7102 Fax: 201.802.7190
	Copyright ©2007 Rho Capital Partners, Inc.